Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. News
  4. >
  5. Himax Technologies, Inc. (HIMX) Set for Augmented Reality Expansion Supported by Analysts and Innovative Technology Initiatives

Himax Technologies, Inc. (HIMX) Set for Augmented Reality Expansion Supported by Analysts and Innovative Technology Initiatives

Written by Emily J. Thompson, Senior Investment Analyst
stocks logo
HIMX.O+1.86%
Source: Yahoo Finance
Updated: 3 hour ago
0mins
Intellectia AI SwingMax
Intellectia AI SwingMax
Source: Yahoo Finance
  • Investment Potential: Himax Technologies Inc. (NASDAQ:HIMX) is considered a promising augmented reality stock with a Moderate Buy rating and a 12-month price target of $10, indicating a potential upside of 32% from its current price of $7.58.

  • Financial Performance: The company reported a 7.3% decline in third-quarter revenue to $199.2 million, alongside an operating loss of $0.6 million, but expects flat revenue in the fourth quarter with slight improvements in gross margins.

  • Technological Advancements: Himax is expanding its offerings in the automotive sector and emerging technologies, including ultralow-power AI chips and smart glasses, while continuing to supply core components for AR devices.

  • Market Position: Despite its potential, some analysts suggest that other AI stocks may offer better upside potential and lower risk, indicating a competitive landscape for investment opportunities.

stocks logo
HIMX.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
no data image
No Data
Powered By
Intellectia
Analyst Views on HIMX
Wall Street analysts forecast HIMX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HIMX is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast HIMX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HIMX is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.080
sliders
Low
10.00
Averages
10.00
High
10.00
Current: 8.080
sliders
Low
10.00
Averages
10.00
High
10.00
Morgan Stanley
Overweight
initiated
$8.80
2025-05-09
Reason
Morgan Stanley
Price Target
$8.80
2025-05-09
initiated
Overweight
Reason
Morgan Stanley initiated coverage of Himax with an Overweight rating and $8.80 price target. Himax is expanding its non-driver integrated circuit business by tapping the growing cloud AI and edge AI markets, the analyst tells investors in a research note. The firm says this bodes well for the company's growth and margin expansion. It expects rising OLED penetration in LDDI and autos to drive Himax's sales growth.
Baird
Tristan Gerra
Buy
Maintains
$7 → $15
2024-12-13
Reason
Baird
Tristan Gerra
Price Target
$7 → $15
2024-12-13
Maintains
Buy
Reason
Baird raised the firm's price target on Himax to $15 from $7 and keeps an Outperform rating on the shares. The firm said Co-Packed Optics and AR opportunities, which reach to the core of Himax's technology capabilities, represent secular growth vectors making Himax worth revisiting as a medium-term speculative investment.
See All Ratings
Financial AI Agent
Financial AI Agent
About HIMX
Himax Technologies Inc is mainly engaged in the fabless semiconductor solution. The Company offers comprehensive automotive integrated circuit (IC) solutions, including traditional driver ICs, in-cell touch and display driver integration, large touch and display driver integration and local dimming timing controllers. The Company's principal product lines include display drivers and timing controllers, touch controller ICs, thin film transistor liquid crystal display (TFT-LCD) television and monitor semiconductor solutions, intellectual property (IP) and application specific integrated circuit (ASIC) service, liquid crystal on silicon (LCOS) and micro-electro mechanical systems (MEMS) products, power ICs, complementary metal-oxide-semiconductor (CMOS) image sensor product, and wafer level optics products.

About the author

Emily J. Thompson
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Top News

Macy’s Surprises with Profit Amid Turnaround Plan

03 Dec 25
news image

Thanksgiving Market Rally: Robinhood, Dell, Deere Moves

27 Nov 25
news image

Best Buy Raises Sales Outlook for Holiday Season

25 Nov 25
news image

Fed's December Rate Cut Odds Rise Amid Debate

22 Nov 25
news image

Related Articles

Fastly Prices $160 Million Convertible Notes Offering, Plans to Repurchase 2026 Notes

14:13 PM
news image

ORIC Pharmaceuticals Reports 35% ORR in HER2 Mutation Patients from Enozertinib Trial

14:13 PM
news image

Sigh Up to Get Intellectia Insights

arrow icon

How did the company's recent strategic decisions impact its latest financial performance?

arrow icon

Can you explain the factors behind the recent changes in the company's stock price?

arrow icon

What are the expected impacts of current market trends on the company's future growth?

arrow icon

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

arrow icon

How does the company's performance compare to its main competitors in the same sector?

People Also Watch

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free